Adjuvant Development Partnership
MF59-like Adjuvant (Product Name: WGa01 Adjuvant)
WGa01 Adjuvant is a squalene-based oil-in-water emulsion adjuvant manufactured using the same production process as MF59 adjuvant. It can be incorporated into recombinant protein vaccines, subunit vaccines, inactivated vaccines, and other vaccine types to enhance the body's adaptive immune response to antigens. We are currently offering complimentary samples and welcome inquiries to establish commercial collaborations (including "Adjuvant-Vaccine Co-Development" and "Adjuvant Production Technology Transfer") to jointly accelerate the R&D and registration of innovative adjuvant-vaccine products.
WestVac Biopharma's MF59-like Adjuvant (WGa01) Collaboration & Service Models — Providing Full Lifecycle Support for Innovative Adjuvant-Vaccine Development
- Free adjuvant samples with usage guidelines for vaccine-antigen compatibility studies
- Regulatory support for adjuvant-related documentation in clinical and registration stages
- Co-development and/or contract manufacturing of adjuvant-vaccine products for clinical trials and commercialization
- Custom adjuvant production for commercial-scale orders
- Technology transfer services for GMP-compliant adjuvant production facility setup
- Retail supply of adjuvants in multiple specifications (10mL, 20mL, 100mL, 10L, 20L) for research institutions and vaccine developers
